AKT1 and breast carcinoma: This is consistent with previous reports that glutathione levels are reduced in MK-2206 treated lung cancer cells45 and that the PI3K/AKT signalling pathway in PIK3CA mutant and PTEN mutant breast cancer cells stimulates glutathione biosynthesis, in order to counteract the effect of oxidative stress.46